Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization

被引:6
|
作者
Lu, Jun Ling [1 ]
Molnar, Miklos Z. [1 ,2 ]
Sumida, Keiichi [1 ,3 ,4 ]
Diskin, Charles D. [5 ]
Streja, Elan [6 ]
Siddiqui, Omer A. [1 ]
Kalantar-Zadeh, Kamyar [6 ]
Kovesdy, Csaba P. [1 ,7 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[2] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary
[3] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan
[4] Univ Tsukuba, Fac Med, Dept Nephrol, Ibaraki, Japan
[5] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA
[6] Univ Calif Irvine, Med Ctr, Harold Simmons Ctr Chron Dis Res & Epidemiol, Div Nephrol & Hypertens, Orange, CA USA
[7] Memphis VA Med Ctr, Nephrol Sect, Memphis, TN 38104 USA
关键词
chronic kidney disease; end-stage renal disease; hospitalization; mortality; pre-ESRD laboratory testing; CHRONIC KIDNEY-DISEASE; PREDIALYSIS NEPHROLOGY CARE; GLOMERULAR-FILTRATION-RATE; SERUM POTASSIUM; OUTCOMES; MANAGEMENT; SURVIVAL; DIALYSIS; ANEMIA; INITIATION;
D O I
10.1093/ndt/gfx192
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Previous studies have demonstrated that early pre-end-stage renal disease (ESRD) nephrology care could improve postdialysis prognosis. However, less is known about the specific types of interventions responsible for the improved outcomes. We hypothesized that more frequent predialysis laboratory testing is associated with better postdialysis outcomes in incident ESRD patients. Methods. In all, 23 089 patients with available outpatient laboratory tests performed during the 2-year predialysis (i.e. prelude) period were identified from a total of 52 172 American veterans with chronic kidney disease (CKD) transitioning to dialysis between October 2007 and September 2011. The associations between the frequency of combined laboratory tests, including serum creatinine, serum potassium and hemoglobin (test trio), with postdialysis mortality and hospitalization were examined in multivariable adjusted Cox and logistic regression models. Results. When entering the 2-year prelude period, the mean age (Standard Deviation) of the patients was 66.2 (SD 11.3) years and the mean estimated glomerular filtration rate was 46.8 (SD 23.9) mL/min/1.73 m(2). In all, 14% of patients had the test trio performed less than twice in 24 months and 8.9% had the trio measured more often than every other month. Over a 2.5-year median postdialysis follow-up period, 15 303 (66.3%) patients died (mortality rate 260/1000 patient-years). The adjusted hazard ratio of all-cause mortality and adjusted odds ratio of the composite of hospitalization or death associated with lab testing done >12/24 months compared with 2-<= 4/24 months were 0.68 [95% confidence interval (CI) 0.65-0.73] and 0.70 (95% CI 0.62-0.79), respectively. Conclusions. More frequent laboratory testing in patients with advanced CKD is associated with better clinical outcomes after dialysis. Further examination in clinical trials is needed before the implementation of more frequent laboratory testing in clinical practice.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 50 条
  • [31] Frequency of Ischemic Heart Disease in Patients of End Stage Renal Disease
    Akhtar, Muhammad Farhan
    Siddque, Hafiz Muhammad Waqas
    Nazir, Talha
    Khan, Ubaid
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (07): : 2059 - 2061
  • [32] Multidisciplinary care program in pre-end-stage kidney disease from 2010 to 2018 in Taiwan
    Lin, Ming-Yen
    Chang, Min-Yu
    Wu, Pei-Yu
    Wu, Ping-Hsun
    Lin, Ming-Huang
    Hsu, Chih-Cheng
    Chang, Jer-Ming
    Hwang, Shang-Jyh
    Chiu, Yi-Wen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 : S64 - S72
  • [33] Relationship Between Age and Pre-End Stage Renal Disease Care in Elderly Patients Treated with Maintenance Hemodialysis
    Harford, Rubette
    Clark, Mary Jo
    Norris, Keith C.
    Yan, Guofen
    NEPHROLOGY NURSING JOURNAL, 2016, 43 (02) : 101 - 107
  • [34] Warfarin Use and Increased Mortality in End-Stage Renal Disease
    Lin, Mark C.
    Streja, Elani
    Soohoo, Melissa
    Hanna, Medhat
    Savoj, Javad
    Kalantar-Zadeh, Kamyar
    Lau, Wei Ling
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (04) : 249 - 256
  • [35] Palliative Care in Patients with End-Stage Renal Disease: A Meta Synthesis
    Imamah, Nur Fithriyanti
    Lin, Hung-Ru
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (20)
  • [36] Quality of Life in End Stage Renal Disease: A Multicentre Comparative Study
    Gayle, F.
    Soyibo, A. K.
    Gilbert, D. T.
    Manzanares, J.
    Barton, E. N.
    WEST INDIAN MEDICAL JOURNAL, 2009, 58 (03) : 235 - 242
  • [37] Rheumatoid Arthritis and Mortality in End Stage Renal Disease
    Paudyal, Sunita
    Waller, Jennifer L.
    Oliver, Alyce
    Le, Brian
    Zleik, Nour
    Nahman, N. Stanley
    Carbone, Laura
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 (02) : 48 - 53
  • [38] Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
    Nakhoul, Georges N.
    Huang, Haiquan
    Arrigain, Susana
    Jolly, Stacey E.
    Schold, Jesse D.
    Nally, Joseph V., Jr.
    Navaneethan, Sankar D.
    AMERICAN JOURNAL OF NEPHROLOGY, 2015, 41 (06) : 456 - 463
  • [39] Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
    Carrero, Juan Jesus
    Grams, Morgan E.
    Sang, Yingying
    Arnlov, Johan
    Gasparini, Alessandro
    Matsushita, Kunihiro
    Qureshi, Abdul R.
    Evans, Marie
    Barany, Peter
    Lindholm, Bengt
    Ballew, Shoshana H.
    Levey, Andrew S.
    Gansevoort, Ron T.
    Elinder, Carl G.
    Coresh, Josef
    KIDNEY INTERNATIONAL, 2017, 91 (01) : 244 - 251
  • [40] Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives
    Scalise, Filippo
    Quarti-Trevano, Fosca
    Toscano, Evelina
    Sorropago, Antonio
    Vanoli, Jennifer
    Grassi, Guido
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2024, 31 (01) : 7 - 13